TYK Medicines-B (02410.HK): Chairman, Executive Director and President intend to further increase shareholding in the Company

date
22/11/2026
Zhitong Finance APP News, TYK Medicines-B (02410.HK) announced that Dr. Wu Yusheng (Dr. Wu), Chairman, Executive Director and President of the Company, has informed the Company that Dr. Wu expects to further purchase shares of the Company in the open market, and the total amount of this share increase is currently expected to not exceed HK$2 million. Dr. Wu has undertaken to the Company that the shares of the Company acquired through the share increase within the next one month will be voluntarily locked up for six months from the date of purchase respectively, and he will not sell or otherwise transfer the relevant shares during the lock-up period. Dr. Wu stated that the funds for this share increase come from his own funds. This share increase demonstrates his firm belief and full confidence in the future development prospects of the Group.